Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis
Kyle Fahrbach, Grammati Sarri, David Phillippo, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 6, pp. 1965-1998
Open Access | Times Cited: 16

Showing 16 citing articles:

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 106
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, Robin Guelimi, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 89
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
Robert Bissonnette, Andreas Pinter, Laura K. Ferris, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 510-521
Closed Access | Times Cited: 31
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis
April W. Armstrong, Kyle Fahrbach, Craig L. Leonardi, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 8, pp. 1777-1792
Open Access | Times Cited: 41
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis
Susanne Klint, Joachim Feldwisch, Lindvi Gudmundsdotter, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 35
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis
April W. Armstrong, Richard B. Warren, Yichen Zhong, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2839-2857
Open Access | Times Cited: 19
Comparing Meta-Analyses with ChatGPT in the Evaluation of the Effectiveness and Tolerance of Systemic Therapies in Moderate-to-Severe Plaque Psoriasis
Xuân‐Lan Lam Hoai, Thierry Simonart
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5410-5410
Open Access | Times Cited: 13
Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis
Richard B. Warren, Kerry Donnelly, Sandeep Kiri, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 11, pp. 3133-3147
Open Access | Times Cited: 2
Childhood Trauma and Psychosocial Stress Affect Treatment Outcome in Patients With Psoriasis Starting a New Treatment Episode
Gloria‐Beatrice Wintermann, Antonie Louise Bierling, Eva M.J. Peters, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 12
Short-term Safety of Dimethyl Fumarate for Psoriasis in Korea
Tae Min Kim, Seong Jin Jo
Annals of Dermatology (2024) Vol. 36, Iss. 4, pp. 252-252
Open Access | Times Cited: 1
Management of moderate to severe psoriasis with brodalumab—Real‐world evidence from the LIBERO study
Ralph von Kiedrowski, Torsten Hinz, Georg Mauer, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 1
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Kristina Callis Duffin, Luis Daniel Mazzuoccolo, M.J. Cura, et al.
The Journal of Rheumatology (2022) Vol. 50, Iss. 1, pp. 131-143
Open Access | Times Cited: 7
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
Vito Di Lernia, Laura Macca, Lucia Peterle, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update
V. D. Sokolova, N. А. Sableva, V. Mladov, et al.
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2022) Vol. 15, Iss. 1, pp. 131-144
Open Access | Times Cited: 3
Psoriatic arthritis
Stephanie Dauth, Maximilian Klippstein, Michaela Köhm
Zeitschrift für Rheumatologie (2023) Vol. 82, Iss. 3, pp. 220-232
Closed Access
Psoriasis treatment: no more room on the summit?
L. Puig
British Journal of Dermatology (2022) Vol. 187, Iss. 6, pp. 837-837
Closed Access
Page 1

Scroll to top